This is the session PRR will be in as per the agenda
Wednesday, January 11, 2012
9:00 - 10:30 AM Hematology & Immunology Analyst: Stephen Dunn, LifeTech Capital
-- Dendreon, David L. Urdal, Executive VP, CSO
-- Prima BioMed, Martin Rogers, CEO
-- ImmunoCellular, Manish Singh, CEO
-- Coronado, Bobby Sandage, CEO
-- bluebird bio, Jeffrey Walsh, COO
-- NexImmune, Ken Carter, CEO
-- Maxcyte, Doug Doerfler, CEO
prr to present@ alliance for regenerative med, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |